A detailed history of Triune Financial Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Triune Financial Partners, LLC holds 633 shares of LLY stock, worth $477,915. This represents 0.18% of its overall portfolio holdings.

Number of Shares
633
Holding current value
$477,915
% of portfolio
0.18%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$772.14 - $960.02 $488,764 - $607,692
633 New
633 $561 Million
Q1 2024

Nov 14, 2024

SELL
$592.2 - $792.28 $10,067 - $13,468
-17 Reduced 2.61%
634 $493 Million
Q4 2023

Nov 14, 2024

SELL
$525.19 - $619.13 $124,470 - $146,733
-237 Reduced 26.69%
651 $380 Million
Q3 2023

Nov 14, 2024

BUY
$434.7 - $599.3 $110,848 - $152,821
255 Added 40.28%
888 $477 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Triune Financial Partners, LLC Portfolio

Follow Triune Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Triune Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Triune Financial Partners, LLC with notifications on news.